Home | Site Map | Contact | Directions

Science

3 GenerationsScience at Ceregene »
Neurotrophic Factors »
Gene Delivery Technology »

Clinical Programs

Participate in a Clinical Trial:

PARKINSON'S DISEASE

Phase 2 Parkinson's Disease
For enrollment information, see www.clinicaltrials.gov
or www.pdtrials.org

ALZHEIMER'S DISEASE

Phase 2 Alzheimer's Disease
In collaboration with Alzheimer's Disease Cooperative Study (ADCS)
For enrollment information, see www.clinicaltrials.gov
or www.adcs.org

Newsroom

06-22-10: The Michael J. Fox Foundation
Awards $2.5 Million to Support Ceregene's
New Phase 2 Neurturin Clinical Study for Parkinson's Disease
»
04-28-10: Ceregene Has Initiated a New
Phase 1/2 Clinical Trial of CERE-120 for Parkinson's Disease
»

Corporate Office:
9381 Judicial Drive, Suite 130
San Diego, CA 92121
T: 858-458-8800
F: 858-458-8801

© Ceregene. All rights reserved.

Ceregene Discoveries
Ceregene Neuron